Treating type 2 diabetes can help fight obesity

A weekly dose of a drug recently approved by the US Food and Drug Administration (FDA) to treat type 2 diabetes can also help adults who do not have the disease to lose weight. reveals a study published in the scientific journal New England Journal of Medicine.

The drug Tirzepatide, sold under the trademark Mounjaro, was tested in people without diabetes using three doses: 5, 10 and 15 milligrams. The results showed that participants who were obese or overweight and who took the five milligram dose lost an average of 16 kg. Those who took the dose of ten milligrams lost an average of 22 kg, and those who took the dose of 15 milligrams lost an average of 23.6 kg.

“Nearly 40% of subjects lost a quarter of their body weight,” said the study’s co-author Ania Jastreboff in statements quoted by CNN.

“The data was pretty impressive,” Robert Gabbay, medical director of the American Diabetes Association, also told CNN. “The weight loss they achieved in this study was even greater than what had been seen in previous studies of people with diabetes,” said the expert, who was not involved in the study.

“The weight loss in the middle class of the persons in this new study was 49 pounds [aproximadamente 22,2kg] “49 pounds is a lot,” he added. “It’s the weight loss area that we usually think is only possible through surgery.”

During the 72-week clinical trial, people without diabetes lost an average of 15 to 20.9 percent of their original body weight. Previous tests on people with diabetes who used the same drug showed that people lost an average of 15 percent of their original body weight.


Leave a Comment

Your email address will not be published.